| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |